Form 4: Marillyn A. Hewson Reports Acquisition of Deferred Share Units in Johnson & Johnson

Director Marillyn A. Hewson reports the acquisition of deferred share units in Johnson & Johnson, to be settled in cash upon termination of directorship.

Summary

• Marillyn A. Hewson, a director of Johnson & Johnson, filed a Form 4 on April 25, 2024, reporting a transaction.
• The transaction involves the acquisition of 1,385.697 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs are to be settled in cash upon termination of Hewson's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• The reporting person directly owns 10,173.4414 derivative securities after the reported transaction.
• The price of the derivative security is $0.0000.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction related to director compensation, indicating stability and alignment of interests. It's a neutral event with a slightly positive implication for corporate governance.

Future Outlook

The Deferred Share Units will be settled in cash upon termination of the Reporting Person's directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.

Industry Context

This filing is a routine disclosure related to director compensation and equity ownership, common in publicly traded companies like Johnson & Johnson.

Stakeholder Impact

• The acquisition of deferred share units aligns the director's interests with those of the shareholders, as the value of the units is tied to the company's stock performance.

Key Dates